Shareholding disclosure

Timothy Dyer

Declared position

10.07%

Threshold

Crossed upwards

Timeline

Published

05.11.2022

Transaction

02.11.2022

Voting rights breakdown

Voting rights acquired10.07%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAMB200044

Beneficial owner

Timothy Dyer

Declared address

Timothy Dyer, 1196 Gland

Crossing down of 15% threshold on share and purchase positions following the capital increase published on SHAB on November 2,2022. Timothy Dyer is the 100% shareholder of TMD Advisory SARL.

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Timothy Dyer

Addex Therapeutics Ltd05.11.2022TAMB200044

Disclosure summary

Timothy Dyer disclosed a holding in Addex Therapeutics Ltd on the acquisition side, published by SIX Exchange Regulation on 05.11.2022, at 10.07% of voting rights. Notice category: Single shareholder.

Disclosed position

10.07%

Voting rights acquired

Voting rights acquired10.07%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Timothy Dyer disclosed a holding in Addex Therapeutics Ltd, published on 05.11.2022.

Publication date05.11.2022

Transaction date02.11.2022

Issuing companyAddex Therapeutics Ltd

Beneficial ownerTimothy Dyer

Declared addressTimothy Dyer, 1196 Gland

CategorySingle shareholder

Voting rights acquired10.07%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAMB200044

Conditions

Crossing down of 15% threshold on share and purchase positions following the capital increase published on SHAB on November 2,2022. Timothy Dyer is the 100% shareholder of TMD Advisory SARL.

Source: SIX Exchange Regulation · Publication date: 05.11.2022

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open